vs

Side-by-side financial comparison of Intuitive Surgical (ISRG) and Roper Technologies (ROP). Click either name above to swap in a different company.

Intuitive Surgical is the larger business by last-quarter revenue ($2.8B vs $2.1B, roughly 1.3× Roper Technologies). Intuitive Surgical runs the higher net margin — 29.8% vs 15.8%, a 14.0% gap on every dollar of revenue. On growth, Intuitive Surgical posted the faster year-over-year revenue change (23.0% vs 11.3%). Over the past eight quarters, Intuitive Surgical's revenue compounded faster (17.4% CAGR vs 10.5%).

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.

ISRG vs ROP — Head-to-Head

Bigger by revenue
ISRG
ISRG
1.3× larger
ISRG
$2.8B
$2.1B
ROP
Growing faster (revenue YoY)
ISRG
ISRG
+11.7% gap
ISRG
23.0%
11.3%
ROP
Higher net margin
ISRG
ISRG
14.0% more per $
ISRG
29.8%
15.8%
ROP
Faster 2-yr revenue CAGR
ISRG
ISRG
Annualised
ISRG
17.4%
10.5%
ROP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ISRG
ISRG
ROP
ROP
Revenue
$2.8B
$2.1B
Net Profit
$826.0M
$331.0M
Gross Margin
66.1%
69.4%
Operating Margin
27.2%
Net Margin
29.8%
15.8%
Revenue YoY
23.0%
11.3%
Net Profit YoY
17.4%
842.6%
EPS (diluted)
$2.28
$4.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISRG
ISRG
ROP
ROP
Q1 26
$2.8B
$2.1B
Q4 25
$2.9B
$2.1B
Q3 25
$2.5B
$2.0B
Q2 25
$2.4B
$1.9B
Q1 25
$2.3B
$1.9B
Q4 24
$2.4B
$1.9B
Q3 24
$2.0B
$1.8B
Q2 24
$2.0B
$1.7B
Net Profit
ISRG
ISRG
ROP
ROP
Q1 26
$826.0M
$331.0M
Q4 25
$794.8M
$428.4M
Q3 25
$704.4M
$398.5M
Q2 25
$658.4M
$378.3M
Q1 25
$698.4M
$331.1M
Q4 24
$685.7M
$462.3M
Q3 24
$565.1M
$367.9M
Q2 24
$526.9M
$337.1M
Gross Margin
ISRG
ISRG
ROP
ROP
Q1 26
66.1%
69.4%
Q4 25
66.4%
69.5%
Q3 25
66.4%
69.5%
Q2 25
66.3%
69.2%
Q1 25
64.7%
68.7%
Q4 24
68.0%
68.3%
Q3 24
67.4%
69.2%
Q2 24
68.3%
69.5%
Operating Margin
ISRG
ISRG
ROP
ROP
Q1 26
27.2%
Q4 25
30.2%
28.6%
Q3 25
30.3%
28.4%
Q2 25
30.5%
28.2%
Q1 25
25.7%
27.9%
Q4 24
30.4%
28.0%
Q3 24
28.3%
28.1%
Q2 24
28.2%
28.8%
Net Margin
ISRG
ISRG
ROP
ROP
Q1 26
29.8%
15.8%
Q4 25
27.7%
20.8%
Q3 25
28.1%
19.8%
Q2 25
27.0%
19.5%
Q1 25
31.0%
17.6%
Q4 24
28.4%
24.6%
Q3 24
27.7%
20.8%
Q2 24
26.2%
19.6%
EPS (diluted)
ISRG
ISRG
ROP
ROP
Q1 26
$2.28
$4.87
Q4 25
$2.19
$3.97
Q3 25
$1.95
$3.68
Q2 25
$1.81
$3.49
Q1 25
$1.92
$3.06
Q4 24
$1.89
$4.29
Q3 24
$1.56
$3.40
Q2 24
$1.46
$3.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISRG
ISRG
ROP
ROP
Cash + ST InvestmentsLiquidity on hand
$382.9M
Total DebtLower is stronger
$9.7B
Stockholders' EquityBook value
$17.6B
$18.8B
Total Assets
$20.1B
$34.6B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISRG
ISRG
ROP
ROP
Q1 26
$382.9M
Q4 25
$5.9B
$297.4M
Q3 25
$4.9B
$320.0M
Q2 25
$5.3B
$242.4M
Q1 25
$4.5B
$372.8M
Q4 24
$4.0B
$188.2M
Q3 24
$4.2B
$269.6M
Q2 24
$4.8B
$251.5M
Total Debt
ISRG
ISRG
ROP
ROP
Q1 26
$9.7B
Q4 25
$9.3B
Q3 25
Q2 25
Q1 25
Q4 24
$7.6B
Q3 24
Q2 24
Stockholders' Equity
ISRG
ISRG
ROP
ROP
Q1 26
$17.6B
$18.8B
Q4 25
$17.8B
$19.9B
Q3 25
$16.9B
$20.0B
Q2 25
$17.8B
$19.6B
Q1 25
$17.1B
$19.2B
Q4 24
$16.4B
$18.9B
Q3 24
$15.6B
$18.5B
Q2 24
$14.7B
$18.1B
Total Assets
ISRG
ISRG
ROP
ROP
Q1 26
$20.1B
$34.6B
Q4 25
$20.5B
$34.6B
Q3 25
$19.4B
$34.6B
Q2 25
$20.2B
$33.2B
Q1 25
$19.2B
$31.4B
Q4 24
$18.7B
$31.3B
Q3 24
$17.7B
$31.6B
Q2 24
$16.6B
$29.8B
Debt / Equity
ISRG
ISRG
ROP
ROP
Q1 26
0.52×
Q4 25
0.47×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISRG
ISRG
ROP
ROP
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$507.0M
FCF MarginFCF / Revenue
24.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISRG
ISRG
ROP
ROP
Q1 26
Q4 25
$892.5M
$738.0M
Q3 25
$841.0M
$869.5M
Q2 25
$715.4M
$404.1M
Q1 25
$581.6M
$528.7M
Q4 24
$822.6M
$722.2M
Q3 24
$706.5M
$755.4M
Q2 24
$620.5M
$384.1M
Free Cash Flow
ISRG
ISRG
ROP
ROP
Q1 26
$507.0M
Q4 25
$730.0M
Q3 25
$735.6M
Q2 25
$560.1M
Q1 25
$465.0M
Q4 24
$510.6M
Q3 24
$458.6M
Q2 24
$311.1M
FCF Margin
ISRG
ISRG
ROP
ROP
Q1 26
24.2%
Q4 25
25.5%
Q3 25
29.4%
Q2 25
23.0%
Q1 25
20.6%
Q4 24
21.2%
Q3 24
22.5%
Q2 24
15.5%
Capex Intensity
ISRG
ISRG
ROP
ROP
Q1 26
0.5%
Q4 25
5.7%
Q3 25
4.2%
Q2 25
6.4%
Q1 25
5.2%
Q4 24
12.9%
Q3 24
12.2%
Q2 24
15.4%
Cash Conversion
ISRG
ISRG
ROP
ROP
Q1 26
Q4 25
1.12×
1.72×
Q3 25
1.19×
2.18×
Q2 25
1.09×
1.07×
Q1 25
0.83×
1.60×
Q4 24
1.20×
1.56×
Q3 24
1.25×
2.05×
Q2 24
1.18×
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISRG
ISRG

Instruments and accessories$1.7B61%
Systems$650.7M23%
Services$433.7M16%

ROP
ROP

Segment breakdown not available.

Related Comparisons